Lilly colon cancer drug succeeds in late stage study By: Reuters: Company News September 12, 2014 at 08:35 AM EDT Sept 12 (Reuters) - Eli Lilly and Co said its colon cancer drug extended survival compared to a placebo, in a late stage trial. Read More >> Related Stocks: Eli Lilly